Thromboxane A2 (TXA2) receptor antagonist improves exercise tolerance in patients with COPD

被引：0
|
作者：
Inoue, T
Mori, M
Matsubara, H
Oguma, T
Okubo, Y
Shiomi, T
Tateno, H
Meguro, Y
Yamaguchi, K
机构：
[1] Keio Univ, Sch Med, Dept Med, Tokyo, Japan
[2] Keio Univ, Sch Med, Hlth Management Ctr, Tokyo, Japan
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 1999年 / 159卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：A802 / A802
页数：1
相关论文
共 50 条
  • [1] ICI-D1542 - A POTENT THROMBOXANE A2 (TXA2) SYNTHASE INHIBITOR AND RECEPTOR ANTAGONIST
    BROWNRIGG, N
    GARCIA, R
    JESSUP, R
    LEE, V
    TUNSTALL, S
    WAYNE, M
    BRITISH JOURNAL OF PHARMACOLOGY, 1992, 107 : P129 - P129
  • [2] Effect of thromboxane A2 (TXA2) synthase inhibitor and TXA2 receptor antagonist alone and in combination on antigen-induced bronchoconstriction in guinea pigs
    Yoshimi, Y
    Fujimura, M
    Myou, S
    Tachibana, H
    Hirose, T
    PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2001, 65 (01) : 1 - 9
  • [3] PHARMACODYNAMICS OF AN INTRAVENOUSLY ADMINISTERED THROMBOXANE (TXA2) RECEPTOR (R) ANTAGONIST
    FRIEDHOFF, LT
    RANIELE, D
    HALSTENSON, CE
    SMITH, SA
    HEDBERG, A
    LIU, E
    SHEPARD, JH
    KEANE, WF
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1989, 45 (02) : 123 - 123
  • [4] Mutations of the platelet thromboxane A2 (TXA2) receptor in patients characterized by the absence of TXA2-induced platelet aggregation despite normal TXA2 binding activity
    Higuchi, W
    Fuse, I
    Hattori, A
    Aizawa, Y
    THROMBOSIS AND HAEMOSTASIS, 1999, 82 (05) : 1528 - 1531
  • [5] Vascular unresponsiveness to thromboxane A2 (TXA2) is associated with a polymorphism at the thromboxane (TP) receptor gene locus.
    Le, TH
    Thomas, DW
    Coffman, TM
    Pfister, SL
    HYPERTENSION, 1999, 34 (02) : 349 - 349
  • [6] BINDING OF A THROMBOXANE A2 PROSTAGLANDIN-H2 (TXA2/PGH2) RECEPTOR ANTAGONIST TO WASHED HUMAN-PLATELETS
    MAIS, DE
    HALUSHKA, PV
    CIRCULATION, 1985, 72 (04) : A7 - A7
  • [7] SYNTHESIS OF HALOGENATED TRIMETOQUINOL DERIVATIVES AND EVALUATION OF THEIR BETA-AGONIST AND THROMBOXANE A2 (TXA2) ANTAGONIST ACTIVITIES
    MARKOVICH, KM
    TANTISHAIYAKUL, V
    HAMADA, A
    MILLER, DD
    ROMSTEDT, KJ
    SHAMS, G
    SHIN, Y
    FRAUNDORFER, PF
    DOYLE, K
    FELLER, DR
    JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (03) : 466 - 479
  • [8] Changes of the plasma levels of thromboxane A2 (TXA2) in patients with different stage of renal failure
    Karamouzis, I.
    Sioulis, A.
    Karamouzis, M.
    Triantos, A.
    Kalaras, K.
    Dimitriadou, A.
    Grekas, D.
    FEBS JOURNAL, 2006, 273 : 159 - 159
  • [9] A THROMBOXANE (TXA2) RECEPTOR ANTAGONIST REDUCES THROMBOXANE PRODUCTION AT THE SITE OF A CORONARY STENOSIS BY INHIBITING PLATELET ACCUMULATION
    SCHMITZ, JM
    ASHTON, JH
    OGLETREE, ML
    TAYLOR, AL
    BUJA, LM
    WILLERSON, JT
    CAMPBELL, WB
    CLINICAL RESEARCH, 1986, 34 (02): : A632 - A632
  • [10] PLATELET ENDOPEROXIDE/THROMBOXANE A2 (PGH2/TXA2) RECEPTORS IN PATIENTS WITH MYELOPROLIFERATIVE DISORDERS
    FAUL, C
    RENN, W
    JASCHONEK, K
    PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 1991, 43 (04): : 273 - 276
12345